We also showed that diverse Nav1.6 mutants displayed distinct responses to CaMKII modulation and revealed that CaMKII inhibition may attenuate gain-of-function effects commonly observed in epilepsy-associated SCN8A mutations. The gene discussed is CAMK2G; the disease is epilepsy.